Unichem Labs gets EIR from USFDA for Goa facility
New Delhi: Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulatorfor the company's plant at Goa.
The company's formulations manufacturing facility at Goa has received an EIR from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing on Friday.
This receipt indicates successful closure of the inspection and queries raised during the audit, it added.
The inspection that was carried out between March 14-20, 2017 has now been closed by the regulator, the company said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd